Stashower Julian, Carr Patrick, Miller Virginia, Zlotoff Barrett
University of Virginia School of Medicine Charlottesville VA USA.
Department of Dermatology University of Virginia School of Medicine Charlottesville VA USA.
Clin Case Rep. 2021 May 4;9(5):e04116. doi: 10.1002/ccr3.4116. eCollection 2021 May.
We present a novel case of an urticaria multiforme-type drug reaction to the new cystic fibrosis medication Trikafta (elexacaftor + tezacaftor + ivacaftor). Equipped with this information, clinicians may be more prepared to counsel and treat patients if they experience similar symptoms after beginning Trikafta.
我们报告了一例对新型囊性纤维化药物Trikafta(依列卡福妥 + 替扎卡福妥 + 依伐卡托)产生多形性荨麻疹型药物反应的新病例。掌握了这些信息后,如果临床医生的患者在开始使用Trikafta后出现类似症状,他们可能会更有准备为患者提供咨询和治疗。